For supplement brands, choosing between a stock formula for Private Label and a custom OEM formulation is an important early product-development decision.
A stock formula can help a brand launch faster with less formulation work, while a custom formula provides greater control over ingredients, dosage, positioning and future product development.
The right choice depends on what the brand is trying to achieve—not simply which option has the lower initial cost.
A Stock Formula / Private Label product is based on an existing formulation offered by a manufacturer. The brand typically selects an available formula and then develops the product under its own branding, packaging and market positioning.
Depending on the manufacturer, some adjustments may be possible, such as packaging, serving size, flavor or selected ingredients. However, the available level of customization depends on the formula structure, ingredient specifications and commercial terms.
Semi-Custom development sits between a standard stock formula and a fully custom OEM formula.
The brand starts with an existing formulation and makes limited modifications based on specific product requirements. Depending on the formula and supplier agreement, this may include adjusting one to three ingredients, changing dosage levels or raw-material specifications, modifying the flavor, adjusting the serving size, or making limited changes to meet target-market requirements.
This approach can provide more flexibility than a standard stock formula without requiring the full development process of a completely new formula.
A fully custom OEM formula is developed specifically around the brand’s product requirements.
Instead of starting from a fixed formula, the manufacturer can evaluate individual raw materials, branded ingredients, supplier premixes, or combinations of these approaches together with dosage, dosage form, manufacturing process, packaging and target-market requirements.
This route provides the greatest degree of formulation flexibility, but it may also require more development work, feasibility evaluation and pilot production before commercial manufacturing.
The main differences are the level of formulation control, development work and flexibility available at each stage.
Evaluation Dimension
Stock / Private Label
Semi-Custom / Modified Stock Formula
Fully Custom OEM Formula
Development Speed
Typically Faster
Moderate
Typically Longer
Formula Control
Typically Limited
Moderate
Typically Higher
Product Differentiation
Typically More Limited
Moderate
Typically Higher
Development Work
Typically Lower
Moderate
Typically Higher
Formula Flexibility
Limited by existing specifications
Selected modifications may be possible
Greater formulation flexibility
Target-Market Flexibility
Depends on existing formula and specifications
Limited market-specific adjustments may be possible
Greater flexibility for target-market requirements
MOQ / Cost
Project-Dependent
Project-Dependent
Project-Dependent
IP / Ownership
Agreement-Dependent
Agreement-Dependent
Agreement-Dependent
These are typical tendencies rather than fixed rules. Actual MOQ, cost, lead time, formula control and IP arrangements depend on the supplier, ingredients, formulation structure, dosage form and commercial agreement.
The level of customization depends on the starting formula and the manufacturer’s development and manufacturing capabilities.
Customization Area
What May Be Adjustable
Ingredient List
Selected ingredients may be added, removed or replaced where technically feasible
Dosage
Ingredient levels or serving size may be adjusted
Raw-Material Specification
Source, grade, standardization or other specifications may be reviewed
Flavor
Flavor system may be adjusted depending on the dosage form
Dosage Form
Certain dosage-form changes may require additional development
Packaging
Bottle, pouch, blister, label or other packaging components may be customized
Target-Market Adaptation
Selected formula or specification changes may be evaluated for the intended market
Development Time
Depends on the extent of modification and whether additional testing or pilot production is required
Actual customization depends on the formula, ingredients, manufacturing process and commercial agreement.
A custom formulation also does not automatically mean that the brand owns all intellectual property. Formula ownership, confidentiality, exclusivity and intellectual-property rights should be defined in the applicable development and manufacturing agreement.
Stock formulas can be particularly practical for brands that want to enter the market quickly or test a product concept before making a larger development investment.
For example, a new Amazon or DTC brand may prefer an existing capsule, gummy, powder or soft-chew formula that already fits its general product positioning. This can reduce formulation-development work and allow the brand to focus earlier on packaging, branding and market launch.
However, the brand should confirm what can actually be changed before selecting the formula. A product that appears customizable on a catalogue page may still have fixed ingredient ratios, serving sizes or raw material specifications.
The important question is therefore not simply “Can I private label this product?”, but “How much control will I have over the product after I select it?”
An existing stock formula should not be assumed to be pre-approved or automatically suitable for every target market. Ingredient status, dosage, claims, product classification and labeling should still be reviewed for the intended market.
The limitations of an existing formula often become more obvious when the brand wants to make changes.
For example, changing one ingredient may affect the formula’s balance, dosage, sensory profile, manufacturing process or cost. A fixed premix or proprietary blend may also require the entire formulation structure to be reviewed rather than allowing one component to be changed independently.
Supplier-controlled raw materials can create another consideration. If a key ingredient becomes unavailable, its specification changes, or its MOQ increases, the brand may need to reformulate or accept changes to the finished product.
For products expected to remain on the market for several years, the brand should also consider how formulation and supplier changes will be managed over time.
Potential change-control issues include:
A commercially successful SKU should therefore be evaluated not only for its first production run, but also for long-term supply continuity and controlled specification changes.
Before commercializing a stock or modified stock formula, the brand should also clarify how formula ownership and exclusivity are handled.
Relevant questions may include:
These terms should be agreed before development or commercialization rather than assumed from the fact that the product is sold under the brand’s own label.
Fully custom OEM formulation becomes more relevant when the brand’s requirements cannot be adequately addressed through an existing stock formula or limited modifications.
This may involve a specific daily dosage, a particular combination of ingredients, a defined cost target, a differentiated product concept or requirements from a specific target market.
Custom development can also be useful when the product is expected to become a core SKU. Instead of adapting the brand to an existing formula, the formulation can be developed around the product strategy from the beginning.
However, greater flexibility usually means more development work. Formula design, feasibility review, prototype or pilot production, testing and approval can all affect the project’s cost and timeline.
The target market should be reviewed before the brand commits to a stock, semi-custom or fully custom formulation route.
Ingredient status, composition, dosage, product classification, claim direction and labeling requirements can vary between markets. A formula suitable for the US market, for example, does not automatically mean it can be launched unchanged in the EU, UK, Australia or New Zealand.
For this reason, a Target-Market Pre-Screen should ideally take place before final formula approval and packaging development.
This early review can prevent a common problem: selecting a formula first and discovering later that the formulation, dosage or claim direction needs to change for the intended market.
A formula can look appropriate on paper and still require changes before commercial production.
The manufacturer may need to evaluate ingredient dosage, bulk density, flowability, blend uniformity, fill weight, ingredient compatibility and dosage-form limitations. For gummies, soft chews or liquid products, sensory and processing considerations may also become important.
This is why a supplement project should not move directly from a formula idea or stock product selection to mass production. A practical development process normally includes concept → feasibility review → prototype / pilot → commercial production, depending on the level of customization required.
The development route can influence the commercial structure, but it does not determine the final quotation by itself.
A stock formula may require less formulation work, yet the project can still be affected by raw material MOQ, packaging MOQ, testing, production batch requirements and finished-goods quantity.
Custom formulation may involve additional development and pilot work, but it can also allow the brand to optimize the formula around its target dosage, product cost and manufacturing requirements.
The better comparison is therefore not simply Private Label = cheaper and Custom OEM = more expensive. The brand should evaluate the total project in terms of MOQ, development cost, manufacturing cost, lead time and long-term product flexibility.
For an overseas brand, the development route can usually be considered through three questions:
If the formula, dosage, dosage form, target market and commercial positioning already fit the project, a Stock Formula / Private Label route may be sufficient.
If only selected changes are required—such as adjusting one to three ingredients, dosage, flavor, serving size or certain raw-material specifications—a Semi-Custom / Modified Stock Formula route may be worth evaluating.
If the brand requires a specific ingredient combination, defined dosage architecture, broader market adaptation or greater formulation control, a Fully Custom OEM route may be more appropriate.
The key is to choose the development route that can meet the brand’s technical, commercial and target-market requirements without adding unnecessary development complexity.
Before approaching a manufacturer, the brand should have a clear understanding of its target market, dosage form, desired formula or product concept, expected production quantity and target product cost.
It is also useful to clarify whether the project requires a Stock Formula / Private Label, Semi-Custom / Modified Stock Formula or Fully Custom OEM Formulation, as this can significantly affect the feasibility review, MOQ, cost and lead time.
Not necessarily.
Yes, in some cases, but the scope varies.
Not automatically.
It depends on the brand’s priorities.
No.
If you are unsure whether to use a stock formula, make limited modifications or develop a fully custom OEM product, a feasibility review can help compare the available routes before you commit to formulation development or production.
Share this page to